|Articles|August 18, 2022
Daily Medication Pearl: Ganciclovir Injection
Author(s)Saro Arakelians, PharmD
Ganciclovir injection is a nucleoside analogue cytomegalovirus DNA polymerase inhibitor.
Advertisement
Medication Pearl of the Day: Ganciclovir Injection
Indication: Ganciclovir injection is a nucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for the treatment of CMV retinitis in immunocompromised adult patients, including patients with AIDS; prevention of CMV disease in adult transplant recipients at risk for CMV disease.
Insight:
- Dosing: 5 mg/kg every 12 hours.
- Dosage forms: Injection 500 mg ganciclovir in 250 mL (2 mg per mL) solution in a single-dose bag for intravenous use.
- Adverse events: Most common adverse reactions and laboratory abnormalities reported in at least 20% of patients were fever, diarrhea, leukopenia, anemia, catheter related events (including catheter infection and catheter sepsis), and elevated creatinine levels.
- Mechanism of action: Ganciclovir is an antiviral drug with activity against CMV.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma
2
IMS 2025: Future Directions for CAR T Therapy in Relapsed and Refractory Multiple Myeloma
3
Updated IMWG Guidelines Spotlight MRD, Functional Imaging, and Light Chain Assays in Multiple Myeloma
4
FDA Approves Bosaya and Aukelso, Biosimilars to Reference Denosumab
5